Elizabeth Donegan, M.D.

Education

University of Missouri 1975

Residencies

UCSF Medical Center, Clinical and Anatomic Pathology 1979

Fellowships

US Public Health Hospital, Anesthesiology 1996

Selected Research and Publications

1. Moncada J, Donegan E, Schachter J. Evaluation of CDC-recommended approaches for confirmatory testing of positive Neisseria gonorrhoeae nucleic acid amplification test results. J Clin Microbiol. 2008 May; 46(5):1614-9.
2. Donegan EA, Wirawan DN, Muliawan P, Schachter J, Moncada J, Parekh M, Knapp JS. Fluoroquinolone-resistant Neisseria gonorrhoeae in Bali, Indonesia: 2004. Sex Transm Dis. 2006 Oct; 33(10):625-9.
3. Pisani E, Girault P, Gultom M, Sukartini N, Kumalawati J, Jazan S, Donegan E. HIV, syphilis infection, and sexual practices among transgenders, male sex workers, and other men who have sex with men in Jakarta, Indonesia. Sex Transm Infect. 2004 Dec; 80(6):536-40.
4. Donegan E, Moncada J, Chernesky M, Schachter J. Sexually transmitted infection/HIV laboratory testing in resource-limited countries: steps to improve use effective testing and to ensure diagnostic capacity. Sex Transm Dis. 2003 Dec; 30(12):905-8.
5. Foley B, Donegan E, Silitonga N, Wignall FS, Busch MP, Delwart EL. Importation of multiple HIV type 1 strains into West Papua, Indonesia (Irian Jaya). AIDS Res Hum Retroviruses. 2001 Nov 20; 17(17):1655-9.
6. Keltner JR, Donegan E, Hynson JM, Shapiro WA. Acute renal failure after radiofrequency liver ablation of metastatic carcinoid tumor. Anesth Analg. 2001 Sep; 93(3):587-9.
7. Leong SP, Donegan E, Heffernon W, Dean S, Katz JA. Adverse reactions to isosulfan blue during selective sentinel lymph node dissection in melanoma. Ann Surg Oncol. 2000 Jun; 7(5):361-6.
8. Korn AP, Hessol NA, Padian NS, Bolan GA, Donegan E, Landers DV, Schachter J. Risk factors for plasma cell endometritis among women with cervical Neisseria gonorrhoeae, cervical Chlamydia trachomatis, or bacterial vaginosis. Am J Obstet Gynecol. 1998 May; 178(5):987-90.
9. Operskalski EA, Stram DO, Busch MP, Huang W, Harris M, Dietrich SL, Schiff ER, Donegan E, Mosley JW. Role of viral load in heterosexual transmission of human immunodeficiency virus type 1 by blood transfusion recipients. Transfusion Safety Study Group. Am J Epidemiol. 1997 Oct 15; 146(8):655-61.
10. Hilton JF, Donegan E, Katz MH, Canchola AJ, Fusaro RE, Greenspan D, Greenspan JS. Development of oral lesions in human immunodeficiency virus-infected transfusion recipients and hemophiliacs. Am J Epidemiol. 1997 Jan 15; 145(2):164-74.
11. Essary LR, Kinard SJ, Butcher A, Wang H, Laycock KA, Donegan E, McCreedy B, Connell S, Batchelor J, Harris J, Spadoro J, Pepose JS. Screening potential corneal donors for HIV-1 by polymerase chain reaction and a colorimetric microwell hybridization assay. Am J Ophthalmol. 1996 Oct; 122(4):526-34.
12. Donegan E, Wright TL, Roberts J, Ascher NL, Lake JR, Neuwald P, Wilber J, Quan S, Kuramoto IK, Dinello RK, et al. Detection of hepatitis C after liver transplantation. Four serologic tests compared. Am J Clin Pathol. 1995 Dec; 104(6):673-9.
13. Korn AP, Hessol N, Padian N, Bolan G, Muzsnai D, Donegan E, Jonte J, Schachter J, Landers DV. Commonly used diagnostic criteria for pelvic inflammatory disease have poor sensitivity for plasma cell endometritis. Sex Transm Dis. 1995 Nov-Dec; 22(6):335-41.
14. Operskalski EA, Stram DO, Lee H, Zhou Y, Donegan E, Busch MP, Stevens CE, Schiff ER, Dietrich SL, Mosley JW. Human immunodeficiency virus type 1 infection: relationship of risk group and age to rate of progression to AIDS. Transfusion Safety Study Group. J Infect Dis. 1995 Sep; 172(3):648-55.
15. Lee TH, Donegan E, Slichter S, Busch MP. Transient increase in circulating donor leukocytes after allogeneic transfusions in immunocompetent recipients compatible with donor cell proliferation. Blood. 1995 Mar 1; 85(5):1207-14.
16. Goodarzi MO, Lee TH, Pallavicini MG, Donegan EA, Busch MP. Unusual kinetics of white cell clearance in transfused mice. Transfusion. 1995 Feb; 35(2):145-9.
17. Gjerset GF, Pike MC, Mosley JW, Hassett J, Fletcher MA, Donegan E, Parker JW, Counts RB, Zhou Y, Kasper CK, et al. Effect of low- and intermediate-purity clotting factor therapy on progression of human immunodeficiency virus infection in congenital clotting disorders. Transfusion Safety Study Group. Blood. 1994 Sep 1; 84(5):1666-71.
18. O'Brien TR, Busch MP, Donegan E, Ward JW, Wong L, Samson SM, Perkins HA, Altman R, Stoneburner RL, Holmberg SD. Heterosexual transmission of human immunodeficiency virus type 1 from transfusion recipients to their sex partners. J Acquir Immune Defic Syndr. 1994 Jul; 7(7):705-10.
19. Donegan E, Lee H, Operskalski EA, Shaw GM, Kleinman SH, Busch MP, Stevens CE, Schiff ER, Nowicki MJ, Hollingsworth CG, et al. Transfusion transmission of retroviruses: human T-lymphotropic virus types I and II compared with human immunodeficiency virus type 1. Transfusion. 1994 Jun; 34(6):478-83.
20. Mosley JW, Nowicki MJ, Kasper CK, Donegan E, Aledort LM, Hilgartner MW, Operskalski EA. Hepatitis A virus transmission by blood products in the United States. Transfusion Safety Study Group. Vox Sang. 1994; 67 Suppl 1:24-8.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions by logging on to UCSF Profiles.